Solid Organ Transplant clinical trials

Explore recruiting solid organ transplant clinical trials.

Recruiting solid organ transplant studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Solid Organ Transplant trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Clinical efficacy and safety of sequential therapy with cryotherapy and topical tirbanibulin 1% in actinic keratoses in transplant recipients: a randomised clinical trial.

Spain

Phase III and phase IV (Integrated) EU CTIS Study details

A Phase 2b, non-randomized, controlled, open-label, extension study to evaluate the persistence of immune response of the adjuvanted RSVPreF3 vaccine and the safety and immunogenicity following revaccination in lung and kidney transplant recipients (≥18 years of age)

Italy, Germany, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

"Full title (English): A Phase 3, open-label, single-arm, repeated-dose study to evaluate the safety and tolerability, pharmacokinetics, and antiviral activity of maribavir for the treatment of cytomegalovirus (CMV) infection in children and adolescents who have received a hematopoietic stem cell transplant (HSCT) or a solid organ transplant (SOT) "

Spain, Belgium, Germany, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Multicenter, Open Label, Phase 3 Study of Tabelecleucel for Solid Organ or Allogeneic Hematopoietic Cell Transplant Subjects with Epstein-Barr VirusAssociated Post-Transplant Lymphoproliferative Disease after Failure of Rituximab or Rituximab and Chemotherapy (ALLELE Study)

Belgium, Spain, Italy, Austria, France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Solid Organ Transplant trials by city

Solid Organ Transplant in Toronto Solid Organ Transplant in Vancouver Solid Organ Transplant in Montreal Solid Organ Transplant in Calgary Solid Organ Transplant in Edmonton Solid Organ Transplant in Ottawa Solid Organ Transplant in Winnipeg Solid Organ Transplant in Quebec City Solid Organ Transplant in Hamilton Solid Organ Transplant in Kitchener Solid Organ Transplant in London Solid Organ Transplant in Halifax Solid Organ Transplant in New York Solid Organ Transplant in Los Angeles Solid Organ Transplant in Chicago Solid Organ Transplant in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease